How can I manage prostate cancer and high PSA level?

Hi,

Welcome to icliniq.com.

I read your query and can understand your concern.

I completely understand how overwhelming this must feel, especially with your family history and the aggressive nature of your diagnosis. The good news is that you are otherwise healthy, you are asking the right questions, and your cancer was caught before there was clear evidence of distant metastasis (spread of cancer cells from the original tumor to distant organs or lymph nodes). This puts you in a strong position to take action and regain control.

Let us walk through your current situation and outline your treatment options clearly while balancing cancer control with your quality of life.

Where you stand: High-risk, possibly locally advanced prostate cancer

Based on your details:

1. Prostate-Specific Antigen (PSA): Rapid rise from 4.2 to 14.7 nanograms per milliliter (ng/mL), suggesting aggressive tumor biology.

2. Gleason Score: 4+5=9 in 8 out of 12 biopsy cores = high-grade disease.

3. Magnetic resonance imaging (MRI): Possible extracapsular extension (likely stage T3a or higher).

4. Computed tomography (CT) Scan: Suspicious 1.1 cm pelvic lymph node (potential N1 involvement).

5. Bone scan: No evidence of distant metastasis—this is reassuring.

6. Symptoms: Urinary urgency, nighttime urination (nocturia), weak stream, dribbling, and lower back pain.

All these findings place the condition in the high-risk to very high-risk category, potentially with locally advanced disease. However, this is still potentially curable with the right treatment approach.

Treatment options

A. Radiation therapy with Androgen Deprivation Therapy (ADT)

This is the standard of care for high-risk or node-positive prostate cancer. It includes:

1. External beam radiation therapy (EBRT): Targeting the prostate, seminal vesicles, and potentially the pelvic lymph nodes.

2. Androgen Deprivation Therapy (ADT): Usually administered for 18 to 36 months. This reduces testosterone levels, which fuel prostate cancer growth.

Benefits:

Non-surgical approach.

1. It can provide excellent long-term cancer control, especially with modern radiation techniques.

2. It may be more suitable if extracapsular extension or nodal disease is confirmed.

Risks:

1. ADT side effects: Hot flashes, fatigue, decreased libido, erectile dysfunction, mood changes, and weight gain.

2. Radiation side effects: Urinary urgency, bowel changes, and gradual decline in erectile function over time.

B. Radical prostatectomy (surgery)

This involves surgical removal of the prostate and surrounding tissues. It may be followed by adjuvant or salvage radiation therapy if:

1. Cancer margins are positive.

2. Seminal vesicle invasion or lymph node involvement is found.

3. Prostate-Specific Antigen (PSA) remains detectable after surgery.

Benefits:

1. The entire cancer-bearing organ is removed.

2. Postoperative pathology gives precise staging.

In younger and healthier patients, it can offer excellent long-term outcomes. Some studies suggest surgery may be associated with better long-term control in high-risk cases.

Risks:

1. Urinary incontinence (5 to 15%).

2. Erectile dysfunction (50 to 70%), especially if nerve-sparing is not feasible.

3. May still require radiation afterward if cancer is found beyond the prostate.

Given the Gleason 9 score and possible extracapsular extension, nerve-sparing surgery may not be possible.

Sexual function and quality of life:

Most men with high-risk prostate cancer experience some decline in sexual function due to:

1. Surgery: Nerve damage affecting erections.

2. Radiation and ADT: Testosterone suppression and vascular changes.

However, some men regain partial or full function over time.

Medications such as Phosphodiesterase-5 inhibitors (like Tadalafil or Cialis), vacuum erection devices, and penile injections can help. Penile rehabilitation programs may support recovery.

Still, preserving life and long-term health must take priority in high-risk cases.

How urgent is the treatment?

Treatment does not need to begin immediately, but it should not be delayed beyond four to six weeks. Gleason 9 tumors can progress if left untreated. Starting treatment within six to eight weeks of diagnosis is considered safe and standard.

In the meantime, ask your doctor about a Prostate-Specific Membrane Antigen Positron Emission Tomography (PSMA PET) scan if it is available. This can help determine whether the pelvic lymph node is truly metastatic.

Next Steps:

It is important to meet with both a urologic oncologist and a radiation oncologist to:

1. Weigh the pros and cons of surgery versus radiation.

2. Ask about nerve-sparing feasibility.

3. Discuss the long-term impacts of Androgen Deprivation Therapy (ADT).

4. Determine whether PSMA PET imaging can provide more clarity.

The fear you are feeling is completely valid, but this situation is not hopeless. This is an aggressive form of prostate cancer, but it is still treatable. With today’s advanced diagnostic tools and treatment methods, there are life-prolonging and even potentially curative options available, even for high-risk prostate cancer.

I hope this helps.

Kindly revert so I can assist you further.

Thank you.